Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Market Growth 2024-2030

Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Market Growth 2024-2030

Monoammonium glycyrrhizinate has hormone like activity, but has no side effects of hormone. It not only has significant curative effects on respiratory diseases such as tracheitis, bronchitis, cough, asthma, but also has marvelous effects on digestive tract infection, hepatitis B, oral ulcer and gastric ulcer. It has strong detoxification effects on many kinds of toxins, such as diphtheria toxin, rapacian toxin, tetanus toxin and snake venom. At the same time, it also has the similar effect of adrenocortical hormone.

The global Pharmaceutical Grade Monoammonium Glycyrrhizinate market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Monoammonium Glycyrrhizinate Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Monoammonium Glycyrrhizinate sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Monoammonium Glycyrrhizinate sales for 2024 through 2030. With Pharmaceutical Grade Monoammonium Glycyrrhizinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Monoammonium Glycyrrhizinate industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Monoammonium Glycyrrhizinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Monoammonium Glycyrrhizinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Monoammonium Glycyrrhizinate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Monoammonium Glycyrrhizinate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Monoammonium Glycyrrhizinate.

United States market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Pharmaceutical Grade Monoammonium Glycyrrhizinate players cover VITAL-CHEM Zhuhai, Sabinsa, Alchem International, Shaanxi Fujie Pharmaceutical and MAFCO Worldwide, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Monoammonium Glycyrrhizinate market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Purity ≥99%
Purity ＜99%

Segmentation by application
Injection
Tablet
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
VITAL-CHEM Zhuhai
Sabinsa
Alchem International
Shaanxi Fujie Pharmaceutical
MAFCO Worldwide
Alps Pharmaceutical
BGG World
Qingdao Taitong Pharmaceutical
Cokey
Jiangsu Tiansheng Pharmaceutical
Shaanxi Jintai Biological Engineering
Qinghai Lake Pharmaceutical
Gansu Sandi
Fanzhi Pharmaceutical
Longtong Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Monoammonium Glycyrrhizinate market?

What factors are driving Pharmaceutical Grade Monoammonium Glycyrrhizinate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Grade Monoammonium Glycyrrhizinate market opportunities vary by end market size?

How does Pharmaceutical Grade Monoammonium Glycyrrhizinate break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.